Experience with long-term therapy in congenital adrenal hyperplasia.
D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000308:Adrenocortical Hyperfunction / Q000150:complications / Q000188:drug therapy*; D001827:Body Height / Q000187:drug effects; D001846:Bone Development / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D003348:Cortisone / Q000008:administration & dosage / Q000627:therapeutic use; D012734:Disorders of Sex Development / Q000150:complications; D004305:Dose-Response Relationship, Drug; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006128:Growth / Q000187:drug effects; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use; D007223:Infant; D007664:Ketosteroids / Q000652:urine; D008297:Male; D008661:Metabolism, Inborn Errors / Q000150:complications; D006899:Mixed Function Oxygenases / Q000378:metabolism; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D011276:Pregnanediol / Q000652:urine; D011279:Pregnanetriol / Q000652:urine; D011629:Puberty, Precocious / Q000150:complications; D013577:Syndrome
D015068:17-Ketosteroids; D005938:Glucocorticoids; D007664:Ketosteroids; D011279:Pregnanetriol; D006899:Mixed Function Oxygenases; D011276:Pregnanediol; D003348:Cortisone; D011241:Prednisone; D006854:Hydrocortisone